Anticoagulant Counter Ion Impact on Bioanalytical LC–MS/MS Assays: Results from Discussions and Experiments Within The European Bioanalysis Forum

Abstract

Based on these results and on conclusions from previous studies, the EBF recommends that in regulated bioanalysis, plasma samples containing different counter ions, but the same anticoagulant, should be regarded as equal matrices, thus removing any need for partial validation.